Drugs firm takes cost conscious doctors to court
Wednesday 25 April 2012
Independent experts have condemned the Swiss pharmaceuticals company Novartis for trying to force the NHS to buy an expensive drug to treat patients suffering from a degenerative eye disease, rather than using a cheaper, unlicensed alternative.
Novartis is taking four NHS areas in the south of England to a judicial review because they have allowed doctors to prescribe the anti-cancer drug Avastin to treat the wet form of age-related macular degeneration.
Novartis wants Southampton, Hampshire, Isle of Wight and Portsmouth to revoke the policy of prescribing Avastin, but is not making any financial claims of the Primary Care Trusts or the NHS.
Novartis says Avastin is unlicensed for the eye disease and wants its own licensed drug Lucentis, which costs £740 an injection compared with £60, to be used.
John Harris, a professor of medical ethics at Manchester University, said companies such as Novartis should not be allowed to block attempts at using more cost-effective treatments to maximise their profits.
"It is legitimate for healthcare providers to appraise and approve off-label treatments which are significantly more cost-effective than those that pharma are prepared to licence," Professor Harris said.
As Voltaire once said, “Ice cream is exquisite. What a pity it isn’t illegal”
Life & Style blogs
Movie pirate given almost 3 years in prison for filming Fast & Furious 6 in back of cinema
What is ALS and the Ice Bucket Challenge?
Mother fed her daughter tapeworms to make her skinny for beauty pageant
Doctors tell Treasury of their anger at rejection of pay reviews
Exclusive: Tickets for Victoria’s Secret Fashion Show in London are not on ‘sale’
- 1 Mother fed her daughter tapeworms to make her skinny for beauty pageant
- 2 Richard Dawkins on babies with Down Syndrome: 'Abort it and try again – it would be immoral to bring it into the world'
- 3 Crystal Palace next manager latest: Palace consider Ally McCoist - EXCLUSIVE
- 4 ALS ice bucket challenge co-founder Corey Griffin drowns, aged 27
- 5 Tim Sherwood column: 'It started as a three-horse race but turned into the Grand National'
£50000 - £60000 per annum: Harrington Starr: Network Engineer - CCNP, Hedge Fu...
£60000 - £70000 per annum: Harrington Starr: Senior Network Engineer-CCIE, Mul...
£30000 - £50000 per annum: Harrington Starr: Network Infrastructure Engineer (...
£35000 - £45000 per annum: Harrington Starr: Network Engineer (CCNP, BGP, Mult...